OncoMatch/Clinical Trials/NCT06085716
Combination Therapy for Cancer Related Fatigue in Patients With Metastatic Cancers
Is NCT06085716 recruiting? Yes, currently enrolling (May 2026). This Phase 2/3 trial studies non-drug interventions for metastatic cancers.
To find out if combining psychoeducational interventions (such as education, counseling, and self-managed therapies) with an open-label placebo can help to improve your quality of life better than either the psychoeducational interventions or the placebo alone.
Check if I qualifyExtracted eligibility criteria
Disease stage
Metastatic disease required
Performance status
ECOG 0–2(Ambulatory, capable of self-care)
Lab requirements
Blood counts
hemoglobin level of ≥10 g/dl within 2 weeks of enrollment
Structured fields extracted by AI. May contain errors — verify against the official protocol.
US trial sites
- MD Anderson Cancer Centerr · Houston, Texas
Showing up to 5 US sites. See all sites on ClinicalTrials.gov →
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualify